InvestSMART

Infratil Limited (ASX:IFT)

ALERT: Price-sensitive ASX Announcement for IFT
Current share price for IFT : $11.450 -1.04 (-8.33%)+
Announcement
Release
6 Jul 2026 7:30AM
Price at Release
$12.490
Full Release
download
Summary
The independent valuation of CDC as of 30 June 2026 indicates a significant increase of 23.6% in value to a midpoint of A$18.5 billion, driven by substantial growth in contracted capacity surpassing 1GW, an accelerated build program, and expansion of the leasable capacity pipeline to 3.9GW by FY40. This valuation includes a notable rise in Infratil's 49.72% interest in CDC to A$9,213 million. Key factors contributing to the valuation growth include increased contracted capacity and the progression of construction activities. Additionally, the cost of equity rose due to a higher risk-free rate and CDC's increased debt-funded development activities.
Key Points
  • CDC's independent valuation increased by 23.6% to A$18.5 billion.
  • Infratil's share in CDC valued at A$9,213 million.
  • Growth driven by over 1GW contracted capacity and expanded capacity pipeline.
  • Cost of equity increased due to a higher risk-free rate.
  • CDC's build program accelerates to support demand.
  • Leasable capacity pipeline extends to 3.9GW by FY40.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.